In fact, chemotherapy in vitro or in vivo leads to an increase in the number of CD44+CD24- CSCs and CD44+CD24- CSCs appears to be more relatively resistant to chemotherapy, which represents a potentially important mechanism of acquired drug resistance in breast cancer [10,11,12]. This evidence concerns the gene CD44 and breast cancer.